Antiviral composition comprising p-menthane-3,8-diol
US7872051B2 · kind B2 · utility
8Cited by
6References
15Claims
0Family size
Inventor
Key dates
| Filing date | Mar 2, 2005 |
| Grant date | Jan 18, 2011 |
| Priority date | — |
| Expiry date | Mar 25, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of p-menthane-3,8-diol (PMD) in the manufacture of a medicament for use as an antiviral agent. The use of PMD in the manufacture of a medicament to destroy or inactivate viruses. The use of PMD, in vitro, as an antiviral or virucidal agent. The use of PMD in the manufacture of a medicament for the treatment of diseases caused by viruses having a lipid envelope. A face mask comprising at least one protective layer impregnated or sprayed with PMD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.